Gene · 488
Papers3,333
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,333
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mitochondrial carrier homolog 2 increases malignant phenotype of human gastric epithelial cells and promotes proliferation, invasion, and migration of gastric cancer cells. | World J Gastrointest Oncol | 2024 | 38577443 | PubTator, text mining | PubMed |
| Persistent Cutaneous Lesions of Darier Disease and Second-Hit Somatic Variants in ATP2A2 Gene. | JAMA Dermatol | 2024 | 38536168 | PubTator, text mining | PubMed |
| Darier disease is associated with neurodegenerative disorders and epilepsy. | Sci Rep | 2024 | 38531956 | PubTator, text mining | PubMed |
| Author Correction: Toll-like receptor 9 protects non-immune cells from stress by modulating mitochondrial ATP synthesis through the inhibition of SERCA2. | EMBO Rep | 2024 | 38429580 | PubTator, text mining | PubMed |
| Identification of a novel nonsense ATP2A2 gene variant in a patient with Darier's disease flare following COVID-19 infection: A case report. | Medicine (Baltimore) | 2024 | 38428853 | PubTator, text mining | PubMed |
| Rescuing SERCA2 pump deficiency improves bone mechano-responsiveness in type 2 diabetes by shaping osteocyte calcium dynamics. | Nat Commun | 2024 | 38291059 | PubTator, text mining | PubMed |
| Physiological and molecular predictors of cycling sprint performance. | Scand J Med Sci Sports | 2024 | 38268080 | PubTator, text mining | PubMed |
| Time-dependent effects of BRAF-V600E on cell cycling, metabolism, and function in engineered myocardium. | Sci Adv | 2024 | 38266090 | PubTator, text mining | PubMed |
| Post-transcriptional mechanisms controlling neurogenesis and direct neuronal reprogramming. | Neural Regen Res | 2024 | 38227517 | PubTator, text mining | PubMed |
| Magnesium chloride-calcium carbonate treatment in a pregnant patient with severe Darier disease. | JAAD Case Rep | 2024 | 38223365 | PubTator, text mining | PubMed |
| miRNAs to the rescue: Reversing heart failure by targeting miR-29. | Mol Ther Nucleic Acids | 2024 | 38222301 | PubTator, text mining | PubMed |
| The translational potential of miR-26 in atherosclerosis and development of agents for its target genes ACC1/2, COL1A1, CPT1A, FBP1, DGAT2, and SMAD7. | Cardiovasc Diabetol | 2024 | 38195542 | PubTator, text mining | PubMed |
| Dysregulation of extracellular vesicle protein cargo in female myalgic encephalomyelitis/chronic fatigue syndrome cases and sedentary controls in response to maximal exercise. | J Extracell Vesicles | 2024 | 38173127 | PubTator, text mining | PubMed |
| Switching of hypertrophic signalling towards enhanced cardiomyocyte identity and maturity by a GATA4-targeted compound. | Stem Cell Res Ther | 2024 | 38167208 | PubTator, text mining | PubMed |
| Sarcolipin relates to fattening, but not sarco/endoplasmic reticulum Ca2+-ATPase uncoupling, in captive migratory gray catbirds. | J Exp Biol | 2024 | 38044822 | PubTator, text mining | PubMed |
| A dual-targeted drug inhibits cardiac ryanodine receptor Ca2+ leak but activates SERCA2a Ca2+ uptake. | Life Sci Alliance | 2024 | 38012000 | PubTator, text mining | PubMed |
| Cardioprotective Strategies After Ischemia-Reperfusion Injury. | Am J Cardiovasc Drugs | 2024 | 37815758 | PubTator, text mining | PubMed |
| Periodontal Treatment of Norwegian Patients With Rare Diseases: A Commentary. | Int Dent J | 2024 | 37743136 | PubTator, text mining | PubMed |
| Exacerbation of Darier disease with lithium therapy. | Dermatol Online J | 2023 | 38478641 | PubTator, text mining | PubMed |
| Late-onset comedonal Darier disease with a novel frameshift mutation in ATP2A2. | Eur J Dermatol | 2023 | 38465553 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/488/papers?page=8